Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS strengthens ties with Mexican university
2010-05-11

 At the First Joint Subcommittee on Technical, Scientific and Technological Co-operation were, from left: Prof. Nahum Marban-Mendoza, Chairperson of the Department of Agroparasitology, UACH; Dr Gisela Pena-Ortega, Director of the Office for International Affairs and Academic Exchange, UACH; Prof. Wijnand Swart, Director of UFS Strategic Academic Cluster 4: Technologies for Crop Industries in Semi-arid regions; and Dr Victor Pinto, Department of Parasitology, UACH.
Photo: Mercedes Cuenca


In 2006, the University of the Free State (UFS) signed an institutional agreement with the Autonomous University of Chapingo (UACH) in Mexico. This made the UFS the first South African academic institution to establish scientific relations with Mexico.

It was for this reason that Prof. Wijnand Swart, Director of the UFS Strategic Academic Cluster 4: Technologies for Crop Industries in Semi-arid regions, was invited to participate in the First Joint Subcommittee on Technical, Scientific and Technological Cooperation held recently in Mexico City. During his visit, Prof. Swart secured the working relationship between the UFS and the UACH.

During the first meeting of the Mexico-South Africa Bi-national Commission, the Mexican Foreign Secretary and Minister of Foreign Affairs and South African Minister for International Relations and Cooperation signed a joint statement. The statement, “Mexico and South Africa: Towards a Priority Relationship”, together with a Scientific and Technological Cooperation Agreement, will lay the foundations for monitoring existing collaboration and promote new actions between institutions in Mexico and South Africa.

Prof. Swart spent the remainder of his stay in Mexico presenting lectures to staff and students at the UACH on integrated pest management and challenges facing South African agriculture. He also engaged in discussions with Dr Gisela Pena-Ortega, Director of the UACH Office for International Affairs and Academic Exchange, about the establishment of a staff and student exchange programme with the UFS.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept